Why is NexgenRx, Inc. ?
1
High Management Efficiency with a high ROE of 17.21%
2
Company has a low Debt to Equity ratio (avg) at times
3
With a growth in Net Profit of 295.22%, the company declared Very Positive results in Sep 25
- The company has declared positive results for the last 4 consecutive quarters
- ROCE(HY) Highest at 17.61%
- DEBT-EQUITY RATIO (HY) Lowest at -387.75 %
- DIVIDEND PAYOUT RATIO(Y) Highest at 64.1%
4
With ROE of 17.41%, it has a expensive valuation with a 3.09 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 36.00%, its profits have risen by 119% ; the PEG ratio of the company is 0
5
Market Beating Performance
- The stock has generated a return of 36.00% in the last 1 year, much higher than market (S&P/TSX 60) returns of 21.87%
How much should you hold?
- Overall Portfolio exposure to NexgenRx, Inc. should be less than 10%
- Overall Portfolio exposure to Miscellaneous should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is NexgenRx, Inc. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
NexgenRx, Inc.
36.0%
0.30
56.57%
S&P/TSX 60
21.87%
1.42
15.41%
Quality key factors
Factor
Value
Sales Growth (5y)
10.70%
EBIT Growth (5y)
-0.20%
EBIT to Interest (avg)
0.73
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-3.16
Sales to Capital Employed (avg)
1.82
Tax Ratio
37.71%
Dividend Payout Ratio
169.49%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
17.21%
Valuation Key Factors 
Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
3.09
EV to EBIT
-6.93
EV to EBITDA
-3.19
EV to Capital Employed
0.29
EV to Sales
-0.42
PEG Ratio
0.04
Dividend Yield
NA
ROCE (Latest)
-3.74%
ROE (Latest)
17.41%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Movement
26What is working for the Company
ROCE(HY)
Highest at 17.61%
DEBT-EQUITY RATIO
(HY)
Lowest at -387.75 %
DIVIDEND PAYOUT RATIO(Y)
Highest at 64.1%
RAW MATERIAL COST(Y)
Fallen by -7.65% (YoY
CASH AND EQV(HY)
Highest at CAD 61.57 MM
PRE-TAX PROFIT(Q)
Highest at CAD 0.57 MM
NET PROFIT(Q)
Highest at CAD 0.59 MM
EPS(Q)
Highest at CAD 0.01
-3What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at CAD -7.08 MM
Here's what is working for NexgenRx, Inc.
Pre-Tax Profit
At CAD 0.57 MM has Grown at 348.61%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CAD MM)
Net Profit
At CAD 0.59 MM has Grown at 295.22%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (CAD MM)
Debt-Equity Ratio
Lowest at -387.75 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Pre-Tax Profit
Highest at CAD 0.57 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CAD MM)
Net Profit
Highest at CAD 0.59 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CAD MM)
EPS
Highest at CAD 0.01
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CAD)
Cash and Eqv
Highest at CAD 61.57 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Dividend Payout Ratio
Highest at 64.1%
in the last five yearsMOJO Watch
Company is distributing higher proportion of profits generated as dividend
DPR (%)
Raw Material Cost
Fallen by -7.65% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for NexgenRx, Inc.
Operating Cash Flow
Lowest at CAD -7.08 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CAD MM)






